Skip to main content
. Author manuscript; available in PMC: 2016 Jan 31.
Published in final edited form as: Cancer Res. 2014 Dec 10;75(3):519–531. doi: 10.1158/0008-5472.CAN-14-2331

Figure 5. miR-155 targets socs1 within MDSCs.

Figure 5

(A) miR-155 expression was measured by the real-time quantitative RT-PCR in splenic Gr1+CD11b+ cells from WT naïve mice, LLC1 tumor-bearing WT mice, and (B) miR-155−/− tumor bearing mice (n=3). (C) Socs1 gene expression was measured by the real-time quantitative RT-PCR in splenic WT or miR-155−/− Gr1+CD11b+ cells from naïve mice and LLC1 tumor-bearing mice (n=5). (D) To identify the function of SOCS1 within Gr1+CD11b+ MDSC, miR-155−/− MDSCs were transfected with siRNAs against SOCS1 or control oligos, and WT MDSCs were also transfected with control oligos by AMAXA. MDSCs 48 h after transfection were added at different ratios to OT-I splenocytes stimulated with OVA-I peptides for 3d, and 3[H] thymidine uptake was measured. Data are given as means ± SEM. Data are representative of 2 independent experiments. *, p<0.05; **, p<0.01.